In a new study published in Lupus Science & Medicine, researchers assessed clinical trial perceptions among a predominantly Black cohort of participants with systemic lupus erythematosus (SLE).

The U.S. Food and Drug Administration (FDA has cleared the investigational new drug (IND) application for Allogene ...

Serving north, central and west Texas, including Dallas/Fort Worth, San Antonio, Austin, El Paso, Lubbock, and surrounding areas Join us for the 2025 Portland Lupus & You Empowerment Conference! Lupus ...

Serving north, central and west Texas, including Dallas/Fort Worth, San Antonio, Austin, El Paso, Lubbock, and surrounding areas Join us for the 2025 Seattle Lupus & You Empowerment Conference! Lupus ...

An investigator-initiated Phase 1/2 trial of CNTY-101, an investigational therapy, has been announced for the treatment of B-cell mediated autoimmune diseases, including systemic lupus erythematosus ...

A new study found that low or absent disease activity, hydroxychloroquine (HCQ) use, and gradual reduction of GC dosing can minimize flare risk and support the successful discontinuation of GCs in ...

This episode of The Expert Series explores the complex relationship between lupus and fibromyalgia, focusing on definitions, symptoms, overlapping conditions, treatment approaches, mental health ...

Join lupus warriors from all over the country for the nation's largest lupus advocacy event of the year! The Lupus Foundation of America's National Lupus Advocacy Summit will take place May 4-6, 2025 ...

Living with lupus can significantly affect your mental health. This January we are honoring Mental Wellness Month by exploring the intersection of lupus and mental health with a four-part series of ...

If your child has lupus, this template letter can help you schedule a meeting with the school to educate their teachers and counselors about lupus and discuss a plan so your child can stay healthy and ...